A new test, developed at the University of Leeds, searches for a heart-type fatty acid-binding protein (H-FABP) which is released into the circulation following heart injury. The test seems to be more accurate in identifying patients with heart damage at an earlier course of their illness.
During a workshop organized by the European Science Foundation (ESF), researchers discussed further steps in developing computerised “in-silico” models of the heart that simulate the real heart and enable possible drugs and therapies to be tested without risk to people.
According to a recently published study in the Journal of Bone and Mineral Research, a vertebral fracture assessment (VFA) examination can be used to measure abdominal aortic calcification (AAC). The level of AAC can predict the likelihood of myocardial infarction as well as stroke among elderly women, independent of other clinical risk factors.
A research carried out at six hospitals in the West Midlands, UK, is evaluating the use of pulse oximetry as a screening tool for congenital heart disease in newborn babies. Approximately three percent of infant deaths are caused by these significant heart defects and at the moment only less than half of the affected babies are identified by clinical examination, the current screening technique.
Recent studies show that drug-eluting-stents perform superior than bare metal stents in the treatment of high-risk cardiac patients. At ComPaMED 2007, the Germany based company HEMOTEQ, leading designer and manufacturer of ultra-thin coatings for medical devices, presented their solutions for customized coating of stents.
Poster data presented at Scientific Sessions 2007 have demonstrated that the application of clinical practice modifications, combined with advanced electronic technologies, can improve the care of patients at risk for sudden cardiac arrest (SCA).
Just in time for Medica, VISUS has expanded its products portfolio with a PACS solution for cardiology.
USA - A team of researchers at the Rochester Institute of Technology, is working to advance the integration of radio frequency identification technology (RFID) into existing cardiac sensor networks, a new wireless technology for telemedicine delivery, and will also work to enhance the security of the systems used.
Sweden - According Canadian physician Neil Skjodt a simple MP3 recording device gave a superior performance in auscultation of lung and heart sounds.
The new £2 million remote access stereotaxis catheter laboratory at London's Heart Hospital, funded by the British Heart Foundation (BHF), is the first of its kind in the UK and one of only 40 worldwide.
Toshiba's new Artida Ultrasound system is the world's first ultrasound system that can track and display myocardial wall motion three-dimensionally.
Magnetic Field Imaging (MFI) provides cardiologists with an additional tool to detect arrythmia and irregular cardiac blood flow and thus contributes to a more precise diagnosis. While an ECG acquires electric signals produced by the activity of the cardiac muscle, MFI measures the electrophysical function of the heart by determining the magnetic field during a heartbeat.
Magnetic Field Imaging (MFI) provides cardiologists with an additional tool to detect arrythmia and irregular cardiac blood flow and thus contributes to a more precise diagnosis. While an ECG acquires electric signals produced by the activity of the cardiac muscle, MFI measures the electrophysical function of the heart by determining the magnetic field during a heartbeat.
A compact portable, easy-to-use ECG machine, the MAC 400, was launched in Europe by GE Healthcare at the recent European Society of Cardiology (ESC).
Since the 1950s, the American Heart Association (AHA) has urged a large number of people to take antibiotics before dental work or other procedures that could flood the bloodstream with bacteria. This antibiotic intake was thought to prevent infective endocarditis.
The Eastern Lithuania Cardiology Project (ELCP) - an integral inter-institutional regional project sponsored by the Lithuanian Government and the European Structural Funds, which began in 2004 - will end this year. In May, those who voted on the Lithuanian EU Support official website (a specially organised event, focusing on all EU-supported projects in all fields) nominated this project as the…
The US firm Boston Scientific reports that it has received the Conformité Européenne (CE) Mark for its Confient implantable cardioverter defibrillator (ICD), the company's first branded cardiac rhythm management device to treat sudden cardiac death. Containing wireless capability, the Confient ICD has been designed to reduce right ventricular pacing.
Results of a gender-specific study to assess the efficacy of the Taxus paclitaxel-eluting coronary stent in women undergoing coronary revascularisation were released at the European Society of Cardiology Congress by interventional device developer Boston Scientific.
The Cardiocentro Ticino in Lugano, Switzerland ' a tertiary care centre specialising in treating patients with coronary artery disease ' carries out around 300 major operations and 2,000 invasive coronary angiographies annually. Six months ago, the hospital acquired state-of-the art equipment, including GE's LightSpeed VCT XT.
The Technology initiative “Molecular Imaging” aims to strengthen the synergies of science and industry in research and development of new technologies in order to significantly improve diagnostic and treatment options, for example for cardiovascular diseases, cancer or Alzheimer's.
By Bodo E. Strauer (Düsseldorf, Germany) Russian summary and complete article in English.
Cordis Corporations' CYPHER stent is a Sirolimus-eluting coronary stent used for treatment of patients with coronary artery disease. The five-year results of the E-Sirius Trial show that in comparison to bare metal stents the CYPHER stent offers sustained clinical benefits.
Coronary stents provide wall wrapping of dissection, prevent elastic recoil, and reduce restenosis after percutaneous transluminal coronary angioplasty. In addition, drug eluting stents loaded with antiproliferative agents inhibit intimal hyperplasia and offer a further reduction of restenosis.
Some of the medical procedures and equipment showcased and discussed at the MEDICA 2007 are sure to provide medical experts with plenty of discussion material. In cardiac diagnostic imaging a minor revolution is taking place, with ultrasound procedures increasing in significance. But innovation in x-ray methods is also continuing.
A new blood pressure (BP) measuring device that provides, along with all the conventional cardiovascular parameters, the cardiac stroke volume, peripheral resistance and arterial augmentation, has been developed at the Austrian Research Centre (ARC), Vienna-Seibersdorf. The result of seven years' work by researchers, the device, named CardioMon, is now ready for sale.